de Vries Lentsch S - Search Results

1

Depressive symptoms during the different phases of a migraine attack: A prospective diary study.

de Vries Lentsch S, Louter MA, van Oosterhout W, van Zwet EW, van Noorden MS, Terwindt GM. de Vries Lentsch S, et al. J Affect Disord. 2022 Jan 15;297:502-507. doi: 10.1016/j.jad.2021.10.046. Epub 2021 Oct 25. J Affect Disord. 2022. PMID: 34710502 Free article.

2

Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study.

Verhagen IE, van Casteren DS, de Vries Lentsch S, Terwindt GM. Verhagen IE, et al. Among authors: de vries lentsch s. Cephalalgia. 2021 Jun;41(7):865-870. doi: 10.1177/0333102420981739. Epub 2021 Jan 11. Cephalalgia. 2021. PMID: 33430642 Free PMC article.

3

E-diary use in clinical headache practice: A prospective observational study.

van Casteren DS, Verhagen IE, de Boer I, de Vries Lentsch S, Fronczek R, van Zwet EW, MaassenVanDenBrink A, Terwindt GM. van Casteren DS, et al. Among authors: de vries lentsch s. Cephalalgia. 2021 Oct;41(11-12):1161-1171. doi: 10.1177/03331024211010306. Epub 2021 May 2. Cephalalgia. 2021. PMID: 33938248 Free PMC article.

4

Treatment with the monoclonal calcitonin gene-related peptide receptor antibody erenumab: A real-life study.

de Vries Lentsch S, Verhagen IE, van den Hoek TC, MaassenVanDenBrink A, Terwindt GM. de Vries Lentsch S, et al. Eur J Neurol. 2021 Dec;28(12):4194-4203. doi: 10.1111/ene.15075. Epub 2021 Sep 7. Eur J Neurol. 2021. PMID: 34424593 Free PMC article.

5

CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab.

de Vries Lentsch S, Al-Hassany L, Ferrari MD, Terwindt GM, MaassenVanDenBrink A. de Vries Lentsch S, et al. J Neurol Neurosurg Psychiatry. 2022 Aug;93(8):911-912. doi: 10.1136/jnnp-2021-327992. Epub 2022 Jan 27. J Neurol Neurosurg Psychiatry. 2022. PMID: 35086941 No abstract available.

6

Serum CGRP in migraine patients using erenumab as preventive treatment.

de Vries Lentsch S, Garrelds IM, Danser AHJ, Terwindt GM, MaassenVanDenBrink A. de Vries Lentsch S, et al. J Headache Pain. 2022 Sep 12;23(1):120. doi: 10.1186/s10194-022-01483-z. J Headache Pain. 2022. PMID: 36089587 Free PMC article.

7

Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study.

de Vries Lentsch S, van der Arend BWH, Maassen VanDenBrink A, Terwindt GM. de Vries Lentsch S, et al. Neurology. 2022 Oct 25;99(17):e1897-e1904. doi: 10.1212/WNL.0000000000201008. Epub 2022 Oct 4. Neurology. 2022. PMID: 36195452 Free PMC article.

8

Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies.

Verhagen IE, de Vries Lentsch S, van der Arend BWH, le Cessie S, MaassenVanDenBrink A, Terwindt GM. Verhagen IE, et al. Among authors: de vries lentsch s. Eur J Neurol. 2023 Jul;30(7):2117-2121. doi: 10.1111/ene.15794. Epub 2023 Apr 6. Eur J Neurol. 2023. PMID: 36941533

9

Characterizing opioid use in a Dutch cohort with migraine.

van Welie RF, van Welie FC, de Vries Lentsch S, Dahan A, van Velzen M, Terwindt GM. van Welie RF, et al. Among authors: de vries lentsch s. Cephalalgia. 2023 May;43(5):3331024231174160. doi: 10.1177/03331024231174160. Cephalalgia. 2023. PMID: 37165775 Free article.

10

Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman's life: Implications for the efficacy and safety of novel antimigraine medications.

de Vries Lentsch S, Rubio-Beltrán E, MaassenVanDenBrink A. de Vries Lentsch S, et al. Maturitas. 2021 Mar;145:73-77. doi: 10.1016/j.maturitas.2020.12.012. Epub 2021 Jan 6. Maturitas. 2021. PMID: 33541566 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters